Dexalot
PrivateLast Round
Grant
Aug 16, 2023
Est. Valuation
$60M
Total Funding Raised
$11.5M
Company Overview
Dexalot operates in Crypto & Web3 and is based in the United States. Its latest recorded funding round was a Grant round in August 2023.
Dexalot is a decentralized finance company that operates a non-custodial, omni-chain decentralized exchange (DEX) featuring an on-chain central limit order book.
Sector
Crypto & Web3
Verticals
Crypto Exchanges, DeFi, Blockchain Infrastructure
Business Model
B2C
Customer Profile
Payment Processing Fee, Usage-Based SaaS
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Dexalot Comparables
Compare Dexalot with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ellipsis Labs | 83% | |
| Ink Foundation | 83% | |
| Hyperliquid | 83% |
For institutional investors. Book with your work email.
Dexalot Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Aug 16, 2023 | ||||
| Private Equity | Feb 17, 2022 | ||||
| Initial Coin Offering | Feb 16, 2022 |
For institutional investors. Book with your work email.
Dexalot Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| GSR Markets | Private Equity |
| Woodstock Fund | Private Equity |
| Avalanche Foundation | Grant |
| Republic Capital | Private Equity |
| Avalaunch | Initial Coin Offering, Private Equity |
| Colony | Private Equity |
| Muhabbit Capital | Private Equity |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 17, 2026
Monthly visitors increased 36% MoM.
- Apr 15, 2025
Monthly visitors grew 96% MoM, reaching 9.6K.
For institutional investors. Book with your work email.
Dexalot Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Dexalot's valuation, stock price, and market status.
Is Dexalot a public or private company?
Dexalot is a private company.
What is the current stock price of Dexalot?
Dexalot is a private company, so its shares have no public market price. Caplight tracks Dexalot's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Dexalot worth (valuation)?
Dexalot's valuation is estimated at $60.0M based on funding round data.
Can I buy Dexalot stock?
Dexalot shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Dexalot's last funding round?
Dexalot's most recent funding round was Grant on August 16, 2023.
Who are the main investors in Dexalot?
Key investors in Dexalot include GSR Markets, Woodstock Fund, Avalanche Foundation, Republic Capital, Avalaunch.
Will Dexalot IPO soon?
No public IPO plans have been announced for Dexalot.
How can I track Dexalot secondary market activity?
Caplight tracks bids, offers, and trades in Dexalot's shares on secondary markets.